Blood-based NfL: A biomarker for differential diagnosis of parkinsonian disorder
about
Neurofilament light protein in blood as a potential biomarker of neurodegeneration in Huntington's disease: a retrospective cohort analysisAdvances in progressive supranuclear palsy: new diagnostic criteria, biomarkers, and therapeutic approaches.Imaging and fluid biomarkers in frontotemporal dementia.Media hype: Patient and scientific perspectives on misleading medical news.Minocycline reduces chronic microglial activation after brain trauma but increases neurodegeneration.Potential clinical utility of multiple system atrophy biomarkers.Diagnosis of multiple system atrophy.Biological, Neuroimaging, and Neurophysiological Markers in Frontotemporal Dementia: Three Faces of the Same Coin.CSF neurofilament light chain and phosphorylated tau 181 predict disease progression in PSP.Prion-like transmission of α-synuclein pathology in the context of an NFL null background.CSF neurofilament proteins as diagnostic and prognostic biomarkers for amyotrophic lateral sclerosis.The technical reliability and biotemporal stability of cerebrospinal fluid biomarkers for profiling multiple pathophysiologies in Alzheimer's disease.Plasma neurofilament light chain levels in patients with MS switching from injectable therapies to fingolimod.Plasma Biomarkers Differentiate Parkinson's Disease From Atypical Parkinsonism Syndromes.Evaluation of RNA Blood Biomarkers in the Parkinson's Disease Biomarkers Program.Emerging Biosensing Technologies for Neuroinflammatory and Neurodegenerative Disease Diagnostics.Serum neurofilament light chain is increased in hereditary spastic paraplegias.Recent Advances in Biomarkers for Parkinson's DiseaseParkinson's Disease Biomarkers: Where Are We and Where Do We Go Next?Detection of Alzheimer's DiseaseCerebrospinal fluid concentrations of inflammatory markers in Parkinson's disease and atypical parkinsonian disordersClinical and Imaging Features of Multiple System Atrophy: Challenges for an Early and Clinically Definitive Diagnosis
P2860
Q30224292-0757A797-7018-4CEA-8B03-C63AE9395A6DQ38666247-33D3D3D2-952F-46F8-A126-B9A2A53867C8Q38670219-003D8D15-721A-4EB8-AA9A-A18F6C151FC6Q40458313-64A8315A-D2ED-4A7E-B722-B9C668398F33Q47260577-1817B8F2-208E-4DFD-84C9-5B90CC940CD6Q47663712-3BFCC3EC-22AC-4E1E-ACF3-96349FFDABD4Q47665262-ABBAF11B-0344-4205-8926-84F3E2B9168AQ47819962-6DA60C36-9860-4263-BB53-11A6C67C29A7Q47893422-9F542BF4-F866-41D4-8D37-C76C3A05B988Q48090188-57DB1098-9404-4E27-AE7C-123250463932Q48265513-9FCAD333-6450-4C93-87F1-8B85F883D074Q50532647-180260B6-6248-4AC4-BE6D-19C92CB01370Q53212006-E406CF44-32C5-419F-9E5D-A6EF21DE3AD1Q55110559-63EE1AB1-B3C1-4269-B03F-44A95FC5A5AEQ55257291-EC4CF75C-BE65-49DB-8595-E40AD2205DA6Q55379242-202EA7C0-2634-4CA9-B834-2A51EB0F7AF5Q55669686-F435A205-226C-41C9-9E13-E5F39DE56F72Q58572579-8CAC80C6-9E5A-4CF2-B6DC-75F69D8A9D11Q58585963-1D149708-E03D-4E44-A4E9-1C2E3B3669CBQ58706105-AFD4ABC1-7B9A-49EE-83B2-6E92CDC8CF83Q58763366-FABCA86E-7DFA-4C88-BD6C-7AC5C55BC1F5Q58791873-EDD2C949-C0A6-4060-96E6-C030FEB7A41C
P2860
Blood-based NfL: A biomarker for differential diagnosis of parkinsonian disorder
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 08 February 2017
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Blood-based NfL: A biomarker for differential diagnosis of parkinsonian disorder
@en
Blood-based NfL: A biomarker for differential diagnosis of parkinsonian disorder.
@nl
type
label
Blood-based NfL: A biomarker for differential diagnosis of parkinsonian disorder
@en
Blood-based NfL: A biomarker for differential diagnosis of parkinsonian disorder.
@nl
prefLabel
Blood-based NfL: A biomarker for differential diagnosis of parkinsonian disorder
@en
Blood-based NfL: A biomarker for differential diagnosis of parkinsonian disorder.
@nl
P2093
P2860
P50
P921
P1433
P1476
Blood-based NfL: A biomarker for differential diagnosis of parkinsonian disorder
@en
P2093
Jan Linder
Lars Forsgren
Nadia Magdalinou
Niklas Norgren
Radu Constantinescu
Shorena Janelidze
Swedish BioFINDER study
Ulf Andreasson
P2860
P304
P356
10.1212/WNL.0000000000003680
P407
P577
2017-02-08T00:00:00Z